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396 CT scans from CF patients screened for lung transplant; the
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Aim: To design a scoring system to quantify structural abnormalities on the CT
scan of CF patients screened for lung transplant with severe advanced lung disease
(SALD).
Methods: We collected 57 CT scans from 3 different transplant centers of CF pa-
tients screened for lung transplant between 1990 and 2005. First, a panel of 3 experts
systematically reviewed a random set of 10 CT scans on eligible items to be used in
a ﬁrst pilot analysis. Included were: bulla/cysts, areas with consolidation/mucous,
air trapping, hyper perfusion, and normal lung tissue. For each CT slice and for
each of the items the surface area of corresponding lung tissue involved is estimated
on a 0–100% scale. Total surface area for the 5 items and each slice adds up to
100%. The ﬁnal SALD score is a mean volume estimate of abnormal and normal
lung tissue.
Results: Pilot analysis of a random subset of CT scans showed a weak correlation
between the SALD and Brody score (p< 0.000, R = 0.578). The intra-observer
variability for both scoring systems was good (Ri = 0.97). The Brody score was
signiﬁcantly higher in one center compared to the other two (p = 0.046 and
p< 0.000). To our surprise, age had a signiﬁcant effect on the Brody score with
scores decreasing with age (p = 0.012). Analysis of the complete set of 57 scans is
nearly completed.
Supported by: The Sophia CF research fund, CF trust RCH.
397 Malignant disease adults with cystic ﬁbrosis: a 10 year review
Z. Khan, I. Clifton, C. Etherington, A. Morton, S. Conway, D. Peckham. Regional
Adult CF Unit, Leeds, United Kingdom
There are concerns regarding an increased risk of cancer in patients with cystic
ﬁbrosis (CF). We aimed to look at the occurrence of malignant disease in a large
population of patients with CF.
We reviewed the case-notes of 372 patients attending the Leeds Adult CF Unit.
Demographics and data regarding a diagnosis of malignant disease were recorded.
A total of 8 patients were diagnosed with a malignant condition over the 10-year
period. The median (range) age of diagnosis was 30.5 years (23−55 years).
5 patients were diagnosed with malignancy post-transplantation. Within this group
of patients there were 2 cases of lymphoproliferative disease, 1 case of basal cell
carcinoma, 1 case of liver cancer and 1 case of small cell lung cancer related
to the donor lung. The median time to diagnosis post-transplantation was 2 years
(1−6 years) with a median (range) age of 26 years (23−55 years). Within this group
2 deaths were attributed to malignancy.
3 patients were diagnosed with a malignant condition without solid organ transplan-
tation. This group consisted of 1 case of pancreatic carcinoma, 1 case of oesophageal
carcinoma and 1 case of bowel carcinoma. The median age of diagnosis in this group
of patients was 44 years (27−55 years). Within this group 2 deaths were attributed
to malignancy.
Prior to transplantation we found all malignant diagnoses were related to the
gastrointestinal tract. Post-transplantation we found a wider variety of malignant
diagnoses, with lymphoproliferative disease commonest. Awareness of the increased
risk of malignant disease is important and appropriate investigations should be
undertaken particularly in patients with atypical symptoms.
398 Renal function in relation to age in cystic ﬁbrosis
S. Giourtzis, M. Fotoulaki, D. Tramma, V. Lafazanis, S. Nousia-Arvanitakis.
Paediatrics, Aristotle University, Thessaloniki, Greece
Introduction: The expression of CFTR in the kidney has been demonstrated. In
spite of the high expression of CFTR in the kidney, patients with CF do not show
major renal dysfunction. Aim: to examine the renal function in CF patients in
relation to age.
Patients: 31 stable CF patients (16 male) aged 11 to 34 (mean 19.5±5.2) years were
included in the study. CF was diagnosed by two sweat chloride concentrations higher
than 60mEq/l. The patients were divided into Group A: 13 patients, aged <17 yrs,
5 male (mean age 13, range 11−16 yrs) and Group B 18 patients (10 male),
aged 17 yrs, (mean age 23.3, range17−34 yrs).
Methods: Markers of glomerular and tubular function were determined: 24-h urine
creatinine, electrolytes, albumin and b2 microglobulin, serum urea, creatinine and
electrolytes, glomerular ﬁltration rate (GFR) and urinary osmotic pressure (UOP)in
a urine sample after water deprivation.
Results: Glomerular Function: GFR was signiﬁcant higher in group B(94.5–
212.6 mean 150ml/min/1.73m2) compared to group A (94.7–141 mean
126.13ml/min/1.73m2) (p< 0.05). GFR was greater than 160ml/min/1.73m2 in
50% of group B and none in group A. Tubular function: Microalbuminuria and
abnormal level of b2 microglobulin (>40.7 g/mol creatinine), were present in the
urine of 4 patients in group B (13%) and none in group A. UOP was low
(<800mOsm) in 7/17 (41.17%) in group B and in 4/13 (30.76%) in group A. All
other blood and urine parameters were normal and comparable in the two groups.
Conclusion: Early signs of renal dysfunction were detected in CF adults. Low
urinary osmotic pressure was an early indicator of renal dysfunction starting in
childhood. Increased GFR may be a sign of hyperﬁltration in CF adults. As the life
expectancy improves, kidney dysfunction requiring special attention may develop.
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Introduction: Urinary incontinence (UI) is a known and internationally recognised
problem in female adults with cystic ﬁbrosis (CF). UI might have a negative impact
on quality of life, but also on lung function, because UI might inﬂuence sputum
evacuation. The prevalence of UI in young patients (<12 years of age) with CF
has not yet been studied extensively. We investigated the prevalence of UI in girls
and female adolescents with CF and the inﬂuence on quality of life and perceived
competence.
Patients and Methods: Questionnaires about micturition symptoms, incontinence,
perceived competence and quality of life were sent to all 12−18-year old female
patients attending our CF center. Parents of all 6−11-year old girls were only asked
to ﬁll out the questionnaire about micturition symptoms.
Results: Fifty-four of 79 patients (68%) completed the questionnaires. The preva-
lence of UI in the total group was 33% (n = 18). Of the 6−11-year old girls 9 of
35 (26%) had UI and 9 of 19 (47%) of the 12−18-year old female patients reported
UI. No signiﬁcant differences in possible risk factors for the development of UI
could be demonstrated. Two of 9 adolescent patients reported that UI had an impact
on quality of life. We found no differences in perceived competence between the
continent and incontinent group.
Conclusion: UI is more common in female CF patients (33%) than would be
expected in the general population of females between 6 and 18 years old (2−10%).
UI has no impact on perceived competence, but can have impact on quality of life.
